Related references
Note: Only part of the references are listed.Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials
Stefan-Alexandru Artene et al.
SCIENTIFIC REPORTS (2018)
Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
Doo-Sik Kong et al.
ONCOTARGET (2017)
Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact
O. Fornara et al.
CELL DEATH AND DIFFERENTIATION (2016)
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
Lee A. Wheeler et al.
NEURO-ONCOLOGY (2016)
Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis
Stefan-Alexandru Artene et al.
ONCOTARGETS AND THERAPY (2016)
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
James Schuster et al.
NEURO-ONCOLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Einar Osland Vik-Mo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study
Giuseppe Stragliotto et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes
Jon D. Laman et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Manfred Westphal et al.
LANCET ONCOLOGY (2013)
Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
X. Jie et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non-Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Thomas J. Lynch et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
Der-Yang Cho et al.
WORLD NEUROSURGERY (2012)
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
Chen-Nen Chang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions
Tony Avril et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
A basic introduction to fixed-effect and random-effects models for meta-analysis
Michael Borenstein et al.
RESEARCH SYNTHESIS METHODS (2010)
EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma
Bryan D. Choi et al.
BRAIN PATHOLOGY (2009)
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
Amy B. Heimberger et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Cell- and peptide-based immunotherapeutic approaches for glioma
Ryuya Yamanaka
TRENDS IN MOLECULAR MEDICINE (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
CNS immune privilege: hiding in plain sight
Monica J. Carson et al.
IMMUNOLOGICAL REVIEWS (2006)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
R Yamanaka et al.
CLINICAL CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
CJ Wheeler et al.
CLINICAL CANCER RESEARCH (2004)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma:: A randomised, controlled study
A Immonen et al.
MOLECULAR THERAPY (2004)
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
NG Rainov
HUMAN GENE THERAPY (2000)
Share Paper
